Silence Therapeutics plc
SLN· Nasdaq
Released Aug 7, 2025, before the open
10-Q filed Aug 7, 2025, 38 days after period end · 0000950170-25-104593
| Metric | Q2 2025 | Q2 2024 |
|---|---|---|
| Revenue | $224.00K | $756.00K |
| Net Income | -$27.35M | -$19.76M |
| EPS Diluted | -$0.19 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Silence Therapeutics plc · CIK 1479615 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2025 · filed Aug 7, 2025 · 38 d after period end
0.2% from the close of Aug 6, 2025 to the close of Aug 7, 2025, the first after the release.